It supports red blood cell production, nerve function, and DNA synthesis
While many menstrual changes during tirzepatide treatment represent benign adaptive responses to weight loss, certain patterns warrant prompt medical evaluation to exclude other underlying conditions
Rebounding is a problem in all kinds of bariatric therapy, but if GLP-1 patients dont incorporate exercise into their routine, they are at risk of an unhealthy cycle of repeatedly sapping their own strength each time they have to go back on the drug
Elevated concentrations of plasma DPP4 are associated with liver disease severity and fibrosis (69)
In the UK, Wegovy tablets are licensed for weight management, while orforglipron is still being studied in clinical trials and is not currently licensed
By following a gradual titration process, most people experience milder side effects that either become manageable or disappear entirely as their body adjusts